Lithium Exposure Induced Changes At Glutamatergic Synapses In Hippocampal Neurons- Insights From In Vitro Electrophysiology And Imaging Studies
Lithium is a drug used to treat mood disorders and also has many side effects, including central nervous system (CNS) complications (such as cognitive dulling), associated with its use. The mechanism of its action still remains unknown. Over the years, many leads have started emerging. It has been s...
Main Author: | Ankolekar, Shreya Maruti |
---|---|
Other Authors: | Sikdar, Sujit K |
Language: | en_US |
Published: |
2016
|
Subjects: | |
Online Access: | http://etd.iisc.ernet.in/handle/2005/2585 http://etd.ncsi.iisc.ernet.in/abstracts/3359/G25449-Abs.pdf |
Similar Items
-
Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium
by: Kosma Sakrajda, et al.
Published: (2021-02-01) -
Review: Accuracy of Salivary Lithium Testing in Treatment Monitoring in Mood Disorders
by: Abbas Ali Asadi, et al.
Published: (2006-04-01) -
Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?
by: Jivan Khlghatyan, et al.
Published: (2018-07-01) -
Ultrasonographically measured change in thyroid status in lithium treated adult patients with mood disorder
by: Sekh Afrar Alam, et al.
Published: (2016-01-01) -
An observational study of 110 elderly lithium-treated patients followed up for 6 years with particular reference to renal function
by: Alberto Bocchetta, et al.
Published: (2017-06-01)